Caitong International Asset Management’s Journey Medical DERM Stock Holding History

Caitong International Asset Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78	Buy	+11	New	+$63	﹤0.01%	2249

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Caitong International Asset Management's DERM Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Journey Medical (DERM) in Q2 2026: 11 shares worth $78. The stake represents ﹤0.01% of the portfolio and ranks #2249 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Caitong International Asset Management held 11 shares of Journey Medical worth $78 as of Q2 2026.
Journey Medical was a new Caitong International Asset Management position in Q2 2026.
Journey Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2249 holding.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.